ResearcherYonsei UniversityActive in the last 2 years
Hyung Keun Lee
Matched on ORCID iD 0000-0002-1123-2136; OpenAlex author ID A5051121123. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper
Papers 5
- Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-024-02676-w↗
- Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-… First author DOI 10.1007/s00262-023-03458-8↗
- Identification of circulating myeloid cells as a potential diagnosis and recurrence marker of pancreatic ductal adenocarcinoma through the single-cell analysis Co-author DOI 10.21203/rs.3.rs-2345667/v1↗
- Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14030853↗
- Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm10184157↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sung Ill Jang · 5 shared papers, 2021–2024 · strength 0.78
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel develop… DOI 10.1007/s00262-023-03458-8↗
- Paper Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14030853↗
- Dong Ki Lee · 5 shared papers, 2021–2024 · strength 0.78
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel develop… DOI 10.1007/s00262-023-03458-8↗
- Paper Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14030853↗
- Eun‐Ju Chang · 4 shared papers, 2021–2024 · strength 0.63
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel develop… DOI 10.1007/s00262-023-03458-8↗
- Paper Characterization of Circulating IL-7R Positive Cell Populations for Early Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/jcm10184157↗
- Joon Seong Park · 3 shared papers, 2022–2024 · strength 0.46
- Paper Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pan… DOI 10.1038/s41416-024-02676-w↗
- Paper Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14030853↗
- Paper Identification of circulating myeloid cells as a potential diagnosis and recurrence marker of pancreatic ductal adenoca… DOI 10.21203/rs.3.rs-2345667/v1↗
- Jae Hee Cho · 2 shared papers, 2022–2023 · strength 0.32
- Sun‐Hee Heo · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.